Esperion Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC | 08/17/2026 | 22.42 M | $70.84 M | 100.00% | 8.92% |
| BLACKROCK, INC. | 08/07/2026 | 22.13 M | $69.92 M | 23.95% | 8.80% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 11.43 M | $36.11 M | 9.52% | 4.55% |
| TRIUM CAPITAL LLP | 07/16/2026 | 11.16 M | $35.26 M | 100.00% | 4.44% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 10.38 M | $32.80 M | 330.65% | 4.13% |
| STATE STREET CORP | 08/07/2026 | 7.28 M | $22.99 M | 3.12% | 2.89% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 7.13 M | $22.52 M | -24.65% | 2.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 6.63 M | $20.96 M | 11.32% | 2.64% |
| AQR ARBITRAGE LLC | 08/14/2026 | 6.05 M | $19.11 M | 100.00% | 2.41% |
| ODDO BHF ASSET MANAGEMENT SAS | 08/13/2026 | 5.00 M | $15.80 M | 100.00% | 1.99% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 4.65 M | $14.71 M | 100.00% | 1.85% |
| FMR LLC | 08/13/2026 | 4.61 M | $14.58 M | 1,131.76% | 1.84% |
| BERYL CAPITAL MANAGEMENT LLC | 08/14/2026 | 4.43 M | $14.00 M | 100.00% | 1.76% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 08/17/2026 | 3.88 M | $12.28 M | -0.19% | 1.55% |
| UBS GROUP AG | 08/13/2026 | 3.84 M | $12.12 M | -10.61% | 1.53% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 3.59 M | $9.83 M | 1,270.61% | 1.43% |
| PSQUARED ASSET MANAGEMENT AG | 08/17/2026 | 3.30 M | $10.43 M | 100.00% | 1.31% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 08/14/2026 | 2.96 M | $9.34 M | 100.00% | 1.18% |
| GABELLI FUNDS LLC | 08/12/2026 | 2.88 M | $9.10 M | 100.00% | 1.15% |
| TIG ADVISORS, LLC | 08/14/2026 | 2.59 M | $8.18 M | 100.00% | 1.03% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.47 M | $7.81 M | -30.03% | 0.98% |
| NORTHERN TRUST CORP | 08/13/2026 | 2.32 M | $7.34 M | 10.35% | 0.92% |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 08/12/2026 | 2.32 M | $7.32 M | 100.00% | 0.92% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.23 M | $7.03 M | 268.29% | 0.89% |
| SAGEFIELD CAPITAL LP | 08/14/2026 | 2.19 M | $6.92 M | 100.00% | 0.87% |
| FIL LTD | 08/13/2026 | 2.11 M | $6.66 M | 100.00% | 0.84% |
| WASATCH ADVISORS LP | 07/10/2026 | 1.93 M | $6.10 M | -87.76% | 0.77% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.74 M | $5.49 M | 11.08% | 0.69% |
| CARMIGNAC GESTION | 08/13/2026 | 1.66 M | $5.24 M | 100.00% | 0.66% |
| LMR PARTNERS LLP | 08/14/2026 | 1.61 M | $5.08 M | 4,381.93% | 0.64% |
| TRANSMARKET HOLDINGS LP | 07/21/2026 | 1.59 M | $5.03 M | 100.00% | 0.63% |
| VOLEON CAPITAL MANAGEMENT LP | 08/14/2026 | 1.55 M | $4.89 M | -19.18% | 0.62% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 08/14/2026 | 1.51 M | $4.77 M | 100.00% | 0.60% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 08/06/2026 | 1.50 M | $4.74 M | 100.00% | 0.60% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.40 M | $4.40 M | 103.72% | 0.56% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 08/12/2026 | 1.37 M | $4.31 M | 100.00% | 0.54% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 1.27 M | $4.00 M | 100.00% | 0.50% |
| MAVEN SECURITIES LTD | 08/14/2026 | 1.24 M | $3.93 M | 100.00% | 0.50% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/14/2026 | 1.14 M | $3.61 M | 100.00% | 0.45% |
| CREDIT INDUSTRIEL ET COMMERCIAL | 07/24/2026 | 1.04 M | $3.30 M | 100.00% | 0.42% |
| CAPULA MANAGEMENT LTD | 08/14/2026 | 930.16 K | $2.94 M | 100.00% | 0.37% |
| WEISS ASSET MANAGEMENT LP | 08/14/2026 | 847.12 K | $2.68 M | 100.00% | 0.34% |
| CHICAGO CAPITAL MANAGEMENT, LLC | 07/22/2026 | 830.94 K | $2.61 M | 100.00% | 0.33% |
| VESTCOR INC | 08/11/2026 | 800.00 K | $2.53 M | 100.00% | 0.32% |
| SOROS FUND MANAGEMENT LLC | 08/14/2026 | 757.36 K | $2.39 M | 100.00% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 742.25 K | $2.35 M | 10.74% | 0.30% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 742.25 K | $2.35 M | 100.00% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 732.62 K | $2.32 M | 31.96% | 0.29% |
| MORGAN STANLEY | 08/13/2026 | 700.67 K | $2.21 M | -74.39% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 657.44 K | $2.08 M | -22.70% | 0.26% |
Esperion Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 345 institutional investors and hedge funds held shares of Esperion Therapeutics Inc.. The most heavily invested institutionals were:
GLAZER CAPITAL, LLC: 22.42 M
BlackRock, Inc.: 22.13 M
VANGUARD CAPITAL MANAGEMENT LLC: 11.43 M
Trium Capital LLP: 11.16 M
GOLDMAN SACHS GROUP INC: 10.38 M
STATE STREET CORP: 7.28 M
80.91% of Esperion Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 249.24 M shares in the last 24 months. This purchase volume represents approximately $757.69 M in transactions.